A new study in BMC Chemistry details the synthesis and characterization of two copper(II) Schiff base complexes, showing that one variant exhibits superior inhibitory activity against jack bean urease ...
A two-year field study in subtropical China shows that amending fertilizers with dual inhibitors and biochar cuts nitrous ...
The difference between 50°F and 55°F soil temps matters more than what you might realize. Here's what the research says about ...
The FDA has granted accelerated approval to Ultomiris (ravulizumab) to reduce proteinuria in adults with primary immunoglobulin A nephropathy at risk for disease progression, making it the first and ...
The U.S. FDA on Wednesday approved AstraZeneca (AZN) subsidiary Alexion's Ultomiris to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk for disease progression.
Alexion, AstraZeneca Rare Disease’s ULTOMIRIS ® (ravulizumab-cwvz) has been approved in the US to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk for disease ...
"This approval is the answer to a question on which we've been relentlessly focused: How do we continue to improve an already effective therapy for daily use?" said Kimberly Moran, PhD, SVP & Head, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results